India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, ...

Generic drugs can save you money, but some could also make you very sick. A new Ohio State University study found that manufacturing differences between the U.S. and other countries, mainly India, can ...

NEW DELHI – Obesity emerged as a central focus of public health policy in India in 2025, driven by a major overhaul of ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

India has banned oral nimesulide formulations above 100 mg, citing liver toxicity risks and safer alternatives. Issued under ...

A new study has found that generic drugs manufactured in India are linked to significantly more severe adverse events — including hospitalization, disability and in some cases death — compared to ...

In FY25, India's pharmaceutical exports reached a record high, surpassing $30 billion (approximately $30.47 billion), a ...

In a major move to strengthen patient safety, India has, for the first time, brought blood components used in transfusions ...

Quality control errors during pharmaceutical manufacturing are unfortunately common occurrences. The majority (around 50%) of employees that work in pharmaceutical manufacturing tend to have duties ...

Manipur’s border with Myanmar is porous, offering ample scope for cartels to traffic a range of narcotics and contraband items. A consignment of drugs that was seized in Manipur, India. Credit: ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...

HYDERABAD, India, Dec 24 (Reuters) - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit ...